Adverse reactions to cromolyn.
The frequency of adverse reactions (dermatitis, myositis, and gastroenteritis) to cromolyn sodium in asthmatic patients was 2% (B/375). Reactions were non-life-threatening and completely reversible. Immunologic evaluations, including skin and serum tests for immediate and delayed reactivity, all were negative. Adverse reactions to cromolyn do not appear to be based on an immunologic mechanism. Cromolyn appears to be a safe drug for the treatment of asthma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D002648:Child; D004205:Cromolyn Sodium / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005759:Gastroenteritis / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009220:Myositis / Q000139:chemically induced*
D004205:Cromolyn Sodium